• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-153通过抑制WWOX促进肝细胞癌中Wnt/β-连环蛋白的激活。

MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.

作者信息

Hua Hong-Wei, Jiang Feng, Huang Qian, Liao Zhijun, Ding Gang

机构信息

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.

Department of Oncology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Chongming Branch, Shanghai 202150, China.

出版信息

Oncotarget. 2015 Feb 28;6(6):3840-7. doi: 10.18632/oncotarget.2927.

DOI:10.18632/oncotarget.2927
PMID:25708809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4414157/
Abstract

Persistent activation of Wnt/β-catenin signaling plays crucial roles in the development of human cancers, including hepatocellular carcinoma (HCC). Here, we performed a MicroRNA-based genetic screen, which revealed a novel diversion in β-catenin signaling triggered by MicroRNA-153 (miR-153). Overexpression of miR-153 was able to promote β-catenin transcriptional activity, leading to cell-cycle progression, proliferation and colony formation of HCC cells. Additionally, systemic administration of miR-153 antigomir suppressed hepatocellular carcinogenesis in a murine liver cancer model. At the molecular level, we found that miR-153 inhibited protein level of WWOX, a tumor suppressor and inhibitor of β-catenin signaling, through targeting its 3'-untranslated region. Therefore, our study highlights the importance of MicroRNA-153/WWOX/β-catenin regulatory axis in the HCC tumorigenesis.

摘要

Wnt/β-连环蛋白信号通路的持续激活在包括肝细胞癌(HCC)在内的人类癌症发展中起着关键作用。在此,我们进行了一项基于微小RNA的基因筛选,结果揭示了由微小RNA-153(miR-153)触发的β-连环蛋白信号通路的一种新分支。miR-153的过表达能够促进β-连环蛋白的转录活性,导致肝癌细胞的细胞周期进程、增殖和集落形成。此外,在小鼠肝癌模型中,全身性给予miR-153反义寡核苷酸可抑制肝细胞癌的发生。在分子水平上,我们发现miR-153通过靶向肿瘤抑制因子及β-连环蛋白信号通路抑制剂WWOX的3'-非翻译区来抑制其蛋白水平。因此,我们的研究突出了微小RNA-153/WWOX/β-连环蛋白调控轴在肝癌发生中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/04b2193c3c8f/oncotarget-06-3840-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/254e3b90367b/oncotarget-06-3840-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/e899859b43a5/oncotarget-06-3840-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/28380d0cf652/oncotarget-06-3840-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/ec194d64ede7/oncotarget-06-3840-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/687f66b06236/oncotarget-06-3840-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/04b2193c3c8f/oncotarget-06-3840-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/254e3b90367b/oncotarget-06-3840-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/e899859b43a5/oncotarget-06-3840-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/28380d0cf652/oncotarget-06-3840-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/ec194d64ede7/oncotarget-06-3840-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/687f66b06236/oncotarget-06-3840-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f5/4414157/04b2193c3c8f/oncotarget-06-3840-g006.jpg

相似文献

1
MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.微小RNA-153通过抑制WWOX促进肝细胞癌中Wnt/β-连环蛋白的激活。
Oncotarget. 2015 Feb 28;6(6):3840-7. doi: 10.18632/oncotarget.2927.
2
Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.miR-432的下调激活Wnt/β-连环蛋白信号通路并促进人肝癌细胞增殖。
Oncotarget. 2015 Apr 10;6(10):7866-79. doi: 10.18632/oncotarget.3492.
3
The expression and significance of WWOX and β-catenin in hepatocellular carcinoma.WWOX 和 β-catenin 在肝细胞癌中的表达及意义。
APMIS. 2013 Feb;121(2):120-6. doi: 10.1111/j.1600-0463.2012.02947.x. Epub 2012 Jul 21.
4
Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.在肝细胞癌中,Wnt/β-连环蛋白信号传导通过上调微小RNA-770来抑制FBXW7的表达。
Tumour Biol. 2016 May;37(5):6045-51. doi: 10.1007/s13277-015-4452-5. Epub 2015 Nov 24.
5
MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.MicroRNA-504 通过抑制卷曲蛋白 7 介导的 Wnt/β-catenin 信号通路在肝癌中发挥肿瘤抑制作用。
Biomed Pharmacother. 2018 Nov;107:754-762. doi: 10.1016/j.biopha.2018.07.150. Epub 2018 Aug 21.
6
MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.miR-214 通过抑制β-catenin 抑制肝癌细胞生长。
Biochem Biophys Res Commun. 2012 Nov 30;428(4):525-31. doi: 10.1016/j.bbrc.2012.10.039. Epub 2012 Oct 12.
7
Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.丙型肝炎病毒诱导的 microRNA-155 上调通过激活 Wnt 信号促进肝癌发生。
Hepatology. 2012 Nov;56(5):1631-40. doi: 10.1002/hep.25849. Epub 2012 Oct 9.
8
Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.端锚聚合酶抑制剂减弱WNT/β-连环蛋白信号传导并抑制肝癌细胞生长。
Oncotarget. 2015 Sep 22;6(28):25390-401. doi: 10.18632/oncotarget.4455.
9
Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.miR-610的下调促进人肝细胞癌的增殖和致瘤性,并激活Wnt/β-连环蛋白信号通路。
Mol Cancer. 2014 Dec 10;13:261. doi: 10.1186/1476-4598-13-261.
10
Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling.假定癌基因COTE1的上调通过调节WWOX信号传导促进人类肝癌发生。
Int J Oncol. 2014 Aug;45(2):719-31. doi: 10.3892/ijo.2014.2482. Epub 2014 Jun 3.

引用本文的文献

1
MiRNA-153 attenuates progression of non-small cell lung cancer through targeting positive regulatory/SET domain 2.微小RNA-153通过靶向正调控/SET结构域2来减缓非小细胞肺癌的进展。
Afr Health Sci. 2024 Sep;24(3):194-204. doi: 10.4314/ahs.v24i3.24.
2
Twenty-five years of WWOX insight in cancer: a treasure trove of knowledge.WWOX在癌症研究领域的25年洞察:知识宝库
Funct Integr Genomics. 2025 May 6;25(1):100. doi: 10.1007/s10142-025-01601-5.
3
Flavonoid GL-V9 suppresses development of human hepatocellular cancer cells by inhibiting Wnt/β-Cantenin signaling pathway.

本文引用的文献

1
Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer.miR-153 通过抑制 AKT 表达发挥其在肺癌中的抗肿瘤活性。
Int J Cancer. 2015 Mar 15;136(6):1333-40. doi: 10.1002/ijc.29103. Epub 2014 Aug 7.
2
Therapeutic targeting of microRNAs: current status and future challenges.治疗性靶向 microRNAs:现状与未来挑战。
Nat Rev Drug Discov. 2014 Aug;13(8):622-38. doi: 10.1038/nrd4359. Epub 2014 Jul 11.
3
WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.WWOX处于癌症、代谢综合征相关特征与中枢神经系统病理学的交叉点。
类黄酮GL-V9通过抑制Wnt/β-连环蛋白信号通路抑制人肝癌细胞的发展。
Discov Oncol. 2025 Apr 4;16(1):462. doi: 10.1007/s12672-025-01845-4.
4
Circ-PAN3 facilitates hepatocellular carcinoma growth via sponging miR-153 and upregulating cyclin D1.环状-PAN3通过吸附miR-153和上调细胞周期蛋白D1促进肝细胞癌生长。
Oncol Res. 2025 Jan 16;33(2):369-380. doi: 10.32604/or.2024.046774. eCollection 2025.
5
LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer.LINC01137/miR-186-5p/WWOX:从膀胱癌中与WWOX相关的RNA相互作用组中鉴定出的一条新轴。
Front Genet. 2023 Jul 13;14:1214968. doi: 10.3389/fgene.2023.1214968. eCollection 2023.
6
MicroRNA‑153 may act as a potential biomarker and prognostic indicator of patients with gastric cancer.微小RNA-153可能作为胃癌患者的潜在生物标志物和预后指标。
Oncol Lett. 2023 May 12;26(1):278. doi: 10.3892/ol.2023.13864. eCollection 2023 Jul.
7
The potential of miR-153 as aggressive prostate cancer biomarker.miR-153作为侵袭性前列腺癌生物标志物的潜力。
Noncoding RNA Res. 2022 Oct 13;8(1):53-59. doi: 10.1016/j.ncrna.2022.10.002. eCollection 2023 Mar.
8
A comprehensive review on miR-153: Mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells.关于miR-153的全面综述:miR-153在癌细胞致瘤性中的作用机制及争议
Front Oncol. 2022 Sep 9;12:985897. doi: 10.3389/fonc.2022.985897. eCollection 2022.
9
Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.步步皆有调控——微小RNA如何驱动肿瘤细胞侵袭与转移
Cancers (Basel). 2020 Dec 10;12(12):3709. doi: 10.3390/cancers12123709.
10
Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.微小RNA-153在人类癌症中的预后及临床病理意义:一项荟萃分析
Medicine (Baltimore). 2020 Nov 13;99(46):e22833. doi: 10.1097/MD.0000000000022833.
Biochim Biophys Acta. 2014 Aug;1846(1):188-200. doi: 10.1016/j.bbcan.2014.06.001. Epub 2014 Jun 14.
4
β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.一种新型肝祖细胞中的β-连环蛋白激活足以引发肝细胞癌和肝母细胞瘤。
Cancer Res. 2014 Aug 15;74(16):4515-25. doi: 10.1158/0008-5472.CAN-13-3275. Epub 2014 May 21.
5
MiR-612 suppresses the stemness of liver cancer via Wnt/β-catenin signaling.微小RNA-612通过Wnt/β-连环蛋白信号通路抑制肝癌的干性。
Biochem Biophys Res Commun. 2014 Apr 25;447(1):210-5. doi: 10.1016/j.bbrc.2014.03.135. Epub 2014 Apr 3.
6
miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway.miR-30-5p 通过靶向致癌性 Wnt/β-catenin/BCL9 通路发挥肿瘤抑制因子和新型治疗工具的作用。
Cancer Res. 2014 Mar 15;74(6):1801-13. doi: 10.1158/0008-5472.CAN-13-3311-T. Epub 2014 Mar 5.
7
Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.常见染色体脆性位点基因 WWOX 在代谢紊乱和肿瘤中的作用。
Int J Biol Sci. 2014 Jan 11;10(2):142-8. doi: 10.7150/ijbs.7727. eCollection 2014.
8
HCC therapies--lessons learned.肝癌治疗——经验教训。
Nat Rev Gastroenterol Hepatol. 2014 Jul;11(7):447-52. doi: 10.1038/nrgastro.2014.10. Epub 2014 Feb 4.
9
Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase.WWOX 肿瘤抑制因子与表皮生长因子受体酪氨酸激酶结合的分子起源。
Biochemistry. 2013 Dec 23;52(51):9223-36. doi: 10.1021/bi400987k. Epub 2013 Dec 13.
10
Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells.下调 miR-200a 通过靶向肝卵圆细胞中的 β-catenin 通路诱导 EMT 表型和 CSC 样特征。
PLoS One. 2013 Nov 15;8(11):e79409. doi: 10.1371/journal.pone.0079409. eCollection 2013.